November 17, 2026
The Impact of the CVS Split in WV
CVS Health plans to split into two independent businesses by 2028 and its potential impact on West Virginia consumers. SHARx…
November 17, 2026
One Prescription Can Rewrite the Benefits Budget, SHARx Warns
As new treatments enter the market with six-and seven-figure prices, SHARx’s Paul Pruitt says employers need to prepare for high-cost…
November 17, 2026
Healthcare in America Might Change After Democratic Midterm Victory
The results of the 2026 midterm elections could influence the direction of U.S. healthcare policy, including healthcare affordability, insurance coverage,…
November 17, 2026
SHARx on KMED: Making Prescription Medications More Affordable
Otto Graham, VP of Sourcing & Pharmacy Relations at SHARx, recently joined The Bill Meyer Show on KMED Radio to…
November 12, 2026
CVS Health Announcement
CVS Health has announced a plan to split into two publicly traded companies by 2028, separating approximately 9,000 CVS pharmacies…
November 9, 2026
SHARx Uses Sports Stories to Spotlight Drug Affordability
In this interview with Martech Edge, Corey explains how SHARx uses sports-related storytelling to bring greater attention to the challenges…
October 28, 2026
Employers Are Overlooking A Better Way To Control Healthcare Costs
With health benefit costs projected to jump dramatically, employers are under intense pressure to trim coverage or shift more expenses…
October 23, 2026
MFN Cuts Manufacturer Prices, But Savings Still Face A Longer Journey
The federal government’s Most-Favored-Nation (MFN) drug pricing initiative promises billions in potential savings, but will those lower manufacturer prices actually…
October 22, 2026
Biosimilars Are Gaining Ground, but PBM Economics Still Shape Access
The growing adoption of biosimilars offers a potential solution to rising prescription drug costs, while pharmacy benefit manager (PBM) economics…
October 19, 2026
SHARx Weighs in on the Future of Affordable Prescription Access
SHARx VP of Sourcing & Pharmacy RelationsĀ Otto Graham shares his perspective on prescription affordability and examines growing concerns among patients…